arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

STAAR SURGICAL CO

STAA
$24.21 ▲ +1.09 (+4.69%) at close
Industrials ·Ophthalmic Goods ·USOphthalmic Goods
67 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
21
Health
Poor
Bearish
auto_awesome

Analytical Summary

STAAR SURGICAL CO faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.2B
Dividend Yield
Revenue Growth 119.6%
Op. Margin 8.5%
ROIC 1.4%
FCF / Share $-0.44
Trailing P/E 242.1x
Price / Book 3.4x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$93.52M
↑ +119.6%
Net Income Profit after all expenses
$5.21M
↑ +128.4%
Operating Margin Operating profit as % of sales
8.5%
↑ +121.6% 6th
FCF / Share Free cash flow per share
$-0.44
↓ -203.9%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
8
Returns
26
Cash Quality
40

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters